• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fundamentals of clinical economics in health interventions.

作者信息

Awasthi S

机构信息

Department of Pediatrics, King George's Medical College, Lucknow.

出版信息

Indian J Pediatr. 2000 May;67(5):352-7. doi: 10.1007/BF02820686.

DOI:10.1007/BF02820686
PMID:10885208
Abstract

Health economics is a science of efficient use of medical resources. Economic evaluation deals with both inputs or costs and outputs or consequences and is done when there are choices. The inputs or costs can be direct, indirect or intangible. The consequences can be measured as natural health units or utilities which aggregate multiple health units or quality adjusted life years. In the current health care scenario in India the cost data is usually lacking. An exact way for estimating the cost is elicitation of opportunity cost which is the value of time or input at its highest. The total cost is the cost of producing a particular quantity of the output and is made up of fixed and variable costs. Fixed costs do not vary with the quantity of output but variable costs do. In India, the total cost of health care provided by a multidisciplinary team can be estimated either by the 'per diem' approach which assumes no cost sharing by the departments, or by the allocation method which takes into account the quantity of service provided by each department and costs them individually. Cost effectiveness or utility and cost-benefit analysis are considered complete economic evaluation. Analyses are done from a pre-specified perspective which could be patients', payers', providers' or societal. Costs incurred at a later time are discounted. Such evaluations help us make informed decision to choose between various health interventions. Their increasing use in health research in the developing countries is needed.

摘要

相似文献

1
Fundamentals of clinical economics in health interventions.
Indian J Pediatr. 2000 May;67(5):352-7. doi: 10.1007/BF02820686.
2
[Introduction to the theory of pharmaco-economics].[药物经济学理论导论]
Rev Med Liege. 1998 May;53(5):230-5.
3
Importance of Economic Evaluation in Health Care: An Indian Perspective.医疗保健中经济评估的重要性:印度视角
Value Health Reg Issues. 2016 May;9:78-83. doi: 10.1016/j.vhri.2015.11.005. Epub 2016 Feb 10.
4
Economic evaluation of vaccination.疫苗接种的经济学评估。
Pharmacoeconomics. 1996;9 Suppl 3:8-15; discussion 23-5. doi: 10.2165/00019053-199600093-00005.
5
Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.估算尼日利亚一家公共卫生机构的精神病院服务成本。
J Ment Health Policy Econ. 2012 Sep;15(3):139-48.
6
Clinical economics review: gastroenterology.临床经济学综述:胃肠病学
Aliment Pharmacol Ther. 1996 Feb;10(1):55-60. doi: 10.1111/j.1365-2036.1996.tb00177.x.
7
Estimating the unit costs of public hospitals and primary healthcare centers.估算公立医院和基层医疗中心的单位成本。
Int J Health Plann Manage. 2013 Oct-Dec;28(4):320-32. doi: 10.1002/hpm.2147. Epub 2012 Nov 5.
8
Cost analysis of a primary health centre in northern India.印度北部一家初级卫生中心的成本分析。
Natl Med J India. 1993 Jul-Aug;6(4):160-3.
9
Economic value of treating lumbar disc herniation in Brazil.巴西腰椎间盘突出症治疗的经济价值。
J Neurosurg Spine. 2016 Apr;24(4):608-14. doi: 10.3171/2015.7.SPINE15441. Epub 2015 Dec 11.
10
Principles of pharmacoeconomic analysis of drug therapy.药物治疗的药物经济学分析原则。
Pharmacoeconomics. 1992 Jan;1(1):20-31. doi: 10.2165/00019053-199201010-00006.

本文引用的文献

1
Measurement of health state utilities for economic appraisal.用于经济评估的健康状态效用测量。
J Health Econ. 1986 Mar;5(1):1-30. doi: 10.1016/0167-6296(86)90020-2.
2
Multi-attribute health status classification systems. Health Utilities Index.多属性健康状况分类系统。健康效用指数。
Pharmacoeconomics. 1995 Jun;7(6):490-502. doi: 10.2165/00019053-199507060-00004.
3
Application of health economics in medical research and clinical epidemiology.健康经济学在医学研究与临床流行病学中的应用。
Indian Pediatr. 1997 Sep;34(9):805-11.
4
Quantifying the burden of disease: the technical basis for disability-adjusted life years.疾病负担的量化:伤残调整生命年的技术基础。
Bull World Health Organ. 1994;72(3):429-45.
5
Cost effectiveness of vaccination against pneumococcal pneumonia.接种肺炎球菌肺炎疫苗的成本效益
N Engl J Med. 1980 Sep 4;303(10):553-9. doi: 10.1056/NEJM198009043031004.
6
Cost-effectiveness of antepartum prevention of Rh immunization.产前预防Rh血型免疫的成本效益
Clin Perinatol. 1984 Jun;11(2):267-81.
7
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs.百日咳与百日咳疫苗。效益、风险及成本的重新分析。
JAMA. 1984 Jun 15;251(23):3109-13. doi: 10.1001/jama.251.23.3109.
8
Economic evaluation of neonatal intensive care of very-low-birth-weight infants.极低出生体重儿新生儿重症监护的经济学评估。
N Engl J Med. 1983 Jun 2;308(22):1330-7. doi: 10.1056/NEJM198306023082206.
9
Benefits, risks and costs of immunization for measles, mumps and rubella.麻疹、腮腺炎和风疹免疫接种的益处、风险及成本
Am J Public Health. 1985 Jul;75(7):739-44. doi: 10.2105/ajph.75.7.739.
10
Clinical economics. A guide to the economic analysis of clinical practices.临床经济学。临床实践经济分析指南。
JAMA. 1989 Nov 24;262(20):2879-86. doi: 10.1001/jama.262.20.2879.